We Like These Underlying Return On Capital Trends At LIMES Schlosskliniken (ETR:LIK)

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Speaking of which, we noticed some great changes in LIMES Schlosskliniken's (ETR:LIK) returns on capital, so let's have a look.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Return On Capital Employed (ROCE): What Is It?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. The formula for this calculation on LIMES Schlosskliniken is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.13 = €4.3m ÷ (€39m - €6.2m) (Based on the trailing twelve months to December 2024).

So, LIMES Schlosskliniken has an ROCE of 13%. On its own, that's a standard return, however it's much better than the 5.7% generated by the Healthcare industry.

See our latest analysis for LIMES Schlosskliniken

While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you'd like to look at how LIMES Schlosskliniken has performed in the past in other metrics, you can view this free graph of LIMES Schlosskliniken's past earnings, revenue and cash flow.

So How Is LIMES Schlosskliniken's ROCE Trending?

LIMES Schlosskliniken has recently broken into profitability so their prior investments seem to be paying off. The company was generating losses five years ago, but now it's earning 13% which is a sight for sore eyes. Not only that, but the company is utilizing 273% more capital than before, but that's to be expected from a company trying to break into profitability. This can tell us that the company has plenty of reinvestment opportunities that are able to generate higher returns.

What We Can Learn From LIMES Schlosskliniken's ROCE

Long story short, we're delighted to see that LIMES Schlosskliniken's reinvestment activities have paid off and the company is now profitable. Since the stock has returned a staggering 344% to shareholders over the last five years, it looks like investors are recognizing these changes. With that being said, we still think the promising fundamentals mean the company deserves some further due diligence.

On the other side of ROCE, we have to consider valuation. That's why we have a FREE intrinsic value estimation for LIK on our platform that is definitely worth checking out.

While LIMES Schlosskliniken may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.